TRUPANION INC (TRUP)
Sector: Financials
2026 Annual Meeting Analysis
TRUPANION INC · Meeting: June 10, 2026
Directors FOR
5
Directors AGAINST
4
Say on Pay
FOR
Auditor
FOR
Director Elections
Election of Directors
Against Analysis
Ms. Davidson has served since 2018 and her full tenure overlaps with Trupanion's severe stock underperformance — the company's shares declined 18.4% over three years while the compensation peer group (as disclosed in the proxy) returned a median of +59.8%, a gap of 78.2 percentage points well above the 20-point trigger; the five-year record is equally poor (-67.5% vs peer median +13.8%), so no long-term mitigant applies.
Dr. Low has been a director since 2006 and his entire tenure overlaps with Trupanion's deep stock underperformance — shares fell 18.4% over three years while the company-disclosed compensation peer group returned a median +59.8%, a gap of 78.2 percentage points far exceeding the 20-point trigger for companies with negative absolute TSR; the five-year picture is equally weak (-67.5% vs peer median +13.8%), so no long-term track-record mitigant is available.
Mr. Rawlings has been a director since 2000 and served as CEO until August 2024, meaning his tenure and leadership fully overlap with the severe underperformance — Trupanion's shares fell 18.4% over three years while the company-disclosed peer group returned a median +59.8% (a 78.2-percentage-point gap exceeding the 20-point trigger), and the five-year record is even worse (-67.5% vs peer median +13.8%), ruling out any long-term mitigant; as an executive director and board chair, he bears direct accountability for this outcome.
Mr. Rubin has served since 2010 and his entire tenure overlaps with Trupanion's sustained underperformance — shares fell 18.4% over three years versus the company-disclosed peer group median of +59.8%, a 78.2-point gap well above the 20-point trigger; the five-year record provides no mitigation (-67.5% vs peer median +13.8%), and as compensation committee chair he also bears specific accountability for the pay-for-performance disconnect discussed separately.
For Analysis
Ms. Dodson joined the board in April 2023, which is less than 36 months before the filing date and less than the full 3-year measurement window, meaning her tenure covers less than half of the underperformance period measured from 2023; under the policy, directors who joined more than 24 months ago but cover less than half the underperformance period are flagged but not automatically voted Against, and no other disqualifying factors (overboarding, attendance, independence) are present.
Mr. Enthoven joined the board in November 2023, which is within approximately 30 months of the 2026 meeting and his tenure covers less than half of the three-year underperformance period; under the policy this warrants a flag but not an automatic Against vote, and no other disqualifying factors are present.
Ms. McLaughlin joined the board in April 2023, and while her tenure is now slightly over 24 months it covers less than half the three-year underperformance window; the policy calls for a flag rather than an automatic Against vote in this circumstance, and no other disqualifying factors (overboarding, attendance, or independence concerns) are present.
Mr. Powell joined the board in October 2025, well within the 24-month new-director exemption window, and is therefore fully exempt from the TSR underperformance trigger; no other disqualifying factors are present.
Ms. Tooth joined the board in 2024 and has served less than 24 months as of the meeting date, placing her within the new-director exemption from the TSR underperformance trigger; she also only became CEO in August 2024, so it is too early to hold her accountable for the multi-year underperformance that predates her tenure, and no other disqualifying factors are present.
Of the nine nominees, four long-tenured directors (Davidson, Low, Rawlings, Rubin — all serving since 2006–2018) receive AGAINST votes because Trupanion's stock declined 18.4% over three years while the company's own disclosed compensation peer group returned a median of +59.8%, a gap of 78.2 percentage points that far exceeds the 20-point trigger applicable to companies with negative absolute TSR; the five-year record (-67.5% vs peer median +13.8%) provides no mitigating offset. The remaining five nominees are supported: Powell and Tooth are within the 24-month new-director exemption, while Dodson, Enthoven, and McLaughlin joined in 2023 and their tenure covers less than half the underperformance window.
Say on Pay
✓ FORCEO
Margi Tooth
Total Comp
$4,113,742
Prior Support
97.8%%
CEO Margi Tooth's total reported compensation of $4.1 million is reasonable for a CEO at a $1.2 billion company in the financial services / specialty insurance space, and prior shareholder support was an overwhelming 97.8%, signaling no historical concern. The pay structure is appropriately weighted toward variable pay — short-term bonuses and stock awards tied to specific financial goals (adjusted operating income, lifetime value per pet, and internal rate of return) made up the majority of total pay, and the 2025 bonus was earned at 147% of target driven by genuine outperformance on two of three metrics, with one metric (IRR) paying out nothing because it missed threshold. While Trupanion's stock has significantly underperformed its peer group over three and five years, the variable pay levels for the CEO do not appear materially above benchmark for the role and company size, the incentive plan contains real performance gates, and the company has a robust clawback policy — so the pay-for-performance alignment check does not trigger a No vote at this juncture.
Auditor Ratification
✓ FORAuditor
Ernst & Young LLP
Tenure
14 yrs
Audit Fees
$2,417,500
Non-Audit Fees
$5,250
Ernst & Young has audited Trupanion since 2012 (approximately 14 years), comfortably below the 25-year tenure threshold that would raise independence concerns; non-audit fees of $5,250 represent only 0.2% of audit fees of $2,417,500, far below the 50% threshold; and Ernst & Young is a Big 4 firm appropriate for a company of Trupanion's size and complexity.
Overall Assessment
The 2026 Trupanion ballot is straightforward with three standard proposals; the principal governance concern is the company's severe and sustained stock underperformance relative to its own disclosed peer group (-78pp over three years, -81pp over five years), which triggers AGAINST votes for four long-tenured directors who bear accountability for that outcome. The auditor ratification and say-on-pay votes both pass cleanly on the merits.
Compensation Peer Group
16 companies disclosed in 2026 proxy filing